Literature DB >> 33580386

Kappa Opioid Receptor Expression and Function in Cells of the Immune System.

Thomas J Rogers1.   

Abstract

The kappa opioid receptor (KOR) is expressed on a number of hematopoietic cell populations, based on both protein binding analysis and the detection of kappa opioid receptor gene (Oprk1) transcripts. There are prominent Oprk1 splice variants that are expressed in the mouse and human brain cells and leukocytes. The activation of KOR results in reduced antibody production, an inhibition of phagocytic cell activity, an inhibition of T cell development, alterations in the production of various pro-inflammatory cytokines, chemokines, and the receptors for these mediators. Finally, the activation of KOR also leads to the regulation of receptor functional activity of chemokine receptors through the process of heterologous desensitization. The functional activity of KOR is important for the regulation of inflammatory responses and may provide opportunities for the development of therapeutics for the treatment of inflammatory disease states.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Analgesia; Chemokine; Cytokine; Dynorphin; HIV-1; Heterologous desensitization; Inflammation; Kappa opioid receptor; Norbinaltorphimine; Protein kinase C; Splice variant; T cell development; U50,488H

Mesh:

Substances:

Year:  2022        PMID: 33580386     DOI: 10.1007/164_2021_441

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  58 in total

Review 1.  Chemoattractant receptor cross-desensitization.

Authors:  H Ali; R M Richardson; B Haribabu; R Snyderman
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Detection of kappa-opioid receptor mRNA in immature T cells.

Authors:  S M Belkowski; J Zhu; L Y Liu-Chen; T K Eisenstein; M W Adler; T J Rogers
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

3.  Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

4.  Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line.

Authors:  S M Belkowski; J Zhu; L Y Liu-Chen; T K Eisenstein; M W Adler; T J Rogers
Journal:  J Neuroimmunol       Date:  1995-10       Impact factor: 3.478

5.  Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages.

Authors:  R N Apte; S K Durum; J J Oppenheim
Journal:  Immunol Lett       Date:  1990-05       Impact factor: 3.685

6.  kappa-Opioid binding sites on a murine lymphoma cell line.

Authors:  J M Bidlack; L D Saripalli; D M Lawrence
Journal:  Eur J Pharmacol       Date:  1992-11-02       Impact factor: 4.432

7.  Characterization of kappa-opioid receptor transcripts expressed by T cells and macrophages.

Authors:  C Alicea; S M Belkowski; J K Sliker; J Zhu; L Y Liu-Chen; T K Eisenstein; M W Adler; T J Rogers
Journal:  J Neuroimmunol       Date:  1998-11-02       Impact factor: 3.478

8.  Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H.

Authors:  C Alicea; S Belkowski; T K Eisenstein; M W Adler; T J Rogers
Journal:  J Neuroimmunol       Date:  1996-01       Impact factor: 3.478

9.  Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.

Authors:  S M Belkowski; C Alicea; T K Eisenstein; M W Adler; T J Rogers
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

10.  CCR2 Signal Facilitates Thymic Egress by Priming Thymocyte Responses to Sphingosine-1-Phosphate.

Authors:  Abudureyimujiang Aili; Jie Zhang; Jia Wu; Haoming Wu; Xiuyuan Sun; Qihua He; Rong Jin; Yu Zhang
Journal:  Front Immunol       Date:  2018-06-07       Impact factor: 7.561

View more
  3 in total

Review 1.  An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects.

Authors:  Alexander R French; Richard M van Rijn
Journal:  Pharmacol Res       Date:  2022-01-29       Impact factor: 7.658

Review 2.  Systemic immune effects of anesthetics and their intracellular targets in tumors.

Authors:  Ting Luan; Yi Li; Lihui Sun; Siqi Xu; Haifeng Wang; Jiansong Wang; Chong Li
Journal:  Front Med (Lausanne)       Date:  2022-07-28

Review 3.  Opioids in cancer: The κ‑opioid receptor (Review).

Authors:  Qier Zhou; Zhiwei Zhang; Songkai Long; Wanjun Li; Baiyun Wang; Na Liang
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.